Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura.

× No keyword cloud information.

6 in total

1. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?

Authors: Sonata Jodele; Benjamin L Laskin; Jens Goebel; Jane C Khoury; Susan L Pinkard; Patricia M Carey; Stella M Davies
Journal: Transfusion Date: 2012-07-15 Impact factor: 3.157

Review 2. Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors: Nay M Tun; Gina M Villani
Journal: J Thromb Thrombolysis Date: 2012-10 Impact factor: 2.300

Review 3. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Authors: Sonata Jodele; Benjamin L Laskin; Christopher E Dandoy; Kasiani C Myers; Javier El-Bietar; Stella M Davies; Jens Goebel; Bradley P Dixon
Journal: Blood Rev Date: 2014-11-28 Impact factor: 8.250

4. [Chinese consensus on the diagnosis and management of transplant-associated thrombotic microangiopathy (2021)].

Authors:
Journal: Zhonghua Xue Ye Xue Za Zhi Date: 2021-03-14

Review 5. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis.

Authors: Joanna A Young; Christopher R Pallas; Mary Ann Knovich
Journal: Bone Marrow Transplant Date: 2021-04-19 Impact factor: 5.174

6. Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.

Authors: Vicky Brocklebank; David Kavanagh
Journal: Clin Kidney J Date: 2017-05-08

6 in total